L Aubree Shay1, Melissa Y Carpentier2, Sally W Vernon2. 1. Department of Health Promotion and Behavioral Sciences, University of Texas School of Public Health, San Antonio Regional Campus, 7411 John Smith Drive, Suite 1100, San Antonio, TX, 78229, USA. laura.aubree.shay@uth.tmc.edu. 2. Department of Health Promotion and Behavioral Sciences, University of Texas School of Public Health, Houston, TX, USA.
Abstract
PURPOSE: We sought to (1) assess prevalence of fear of recurrence among cancer survivors diagnosed as adolescent and young adults (AYA; 15-39 years) versus those diagnosed at a later age (40+ years) and (2) identify factors associated with fear of recurrence in each group. METHODS: We used logistic regression to determine the correlates of fear of recurrence by age group at diagnosis among survivors responding to the 2010 LIVESTRONG survey. RESULTS: Prevalence of fear of recurrence was significantly higher among AYA survivors (85.2 %) than those diagnosed at an older age (79.7 %). Among AYA respondents, being employed and less than 5 years off treatment were positively associated with fear of recurrence while those with thyroid cancer and those who participated in a clinical trial were less likely to experience fear of recurrence. Among older adults, receipt of surgery was associated with fear of recurrence whereas having insurance coverage through Medicare or Medicaid and positive patient-provider communication were negatively associated with fear of recurrence. CONCLUSIONS: For both AYA and older adult survivors, changeable factors such as having a more positive cancer care experience may impact fear of recurrence. Our findings highlight the need to identify and understand aspects of the communication process that can be targeted in future interventions with survivors and healthcare providers to ensure that fear of recurrence is being appropriately managed. Factors associated with fear of recurrence differ for AYA and older adult survivors; thus, interventions would likely benefit from tailoring based on age at diagnosis.
PURPOSE: We sought to (1) assess prevalence of fear of recurrence among cancer survivors diagnosed as adolescent and young adults (AYA; 15-39 years) versus those diagnosed at a later age (40+ years) and (2) identify factors associated with fear of recurrence in each group. METHODS: We used logistic regression to determine the correlates of fear of recurrence by age group at diagnosis among survivors responding to the 2010 LIVESTRONG survey. RESULTS: Prevalence of fear of recurrence was significantly higher among AYA survivors (85.2 %) than those diagnosed at an older age (79.7 %). Among AYA respondents, being employed and less than 5 years off treatment were positively associated with fear of recurrence while those with thyroid cancer and those who participated in a clinical trial were less likely to experience fear of recurrence. Among older adults, receipt of surgery was associated with fear of recurrence whereas having insurance coverage through Medicare or Medicaid and positive patient-provider communication were negatively associated with fear of recurrence. CONCLUSIONS: For both AYA and older adult survivors, changeable factors such as having a more positive cancer care experience may impact fear of recurrence. Our findings highlight the need to identify and understand aspects of the communication process that can be targeted in future interventions with survivors and healthcare providers to ensure that fear of recurrence is being appropriately managed. Factors associated with fear of recurrence differ for AYA and older adult survivors; thus, interventions would likely benefit from tailoring based on age at diagnosis.
Entities:
Keywords:
Adolescent and young adult; Cancer survivor; Correlates; Fear of recurrence; Prevalence
Authors: Kuang-Yi Wen; Suzanne M Miller; Annette L Stanton; Linda Fleisher; Marion E Morra; Alexandra Jorge; Michael A Diefenbach; Mary E Ropka; Alfred C Marcus Journal: Patient Educ Couns Date: 2012-07-07
Authors: Tone Skaali; Sophie D Fosså; Roy Bremnes; Olav Dahl; Carl Fredrik Haaland; Erik Rønneberg Hauge; Olbjørn Klepp; Jan Oldenburg; Erik Wist; Alv A Dahl Journal: Psychooncology Date: 2009-06 Impact factor: 3.894
Authors: Gary Rodin; Jean A Mackay; Camilla Zimmermann; Carole Mayer; Doris Howell; Mark Katz; Jonathan Sussman; Melissa Brouwers Journal: Support Care Cancer Date: 2009-03-04 Impact factor: 3.603
Authors: Belinda Thewes; Suzanne E J Kaal; Jose A E Custers; Eveliene Manten-Horst; Rosemarie Jansen; Petra Servaes; Winette T A van der Graaf; Judith B Prins; Olga Husson Journal: Support Care Cancer Date: 2017-11-22 Impact factor: 3.603
Authors: Ursula M Sansom-Daly; Claire E Wakefield; Sarah J Ellis; Brittany C McGill; Mark W Donoghoe; Phyllis Butow; Richard A Bryant; Susan M Sawyer; Pandora Patterson; Antoinette Anazodo; Megan Plaster; Kate Thompson; Lucy Holland; Michael Osborn; Fiona Maguire; Catherine O'Dwyer; Richard De Abreu Lourenco; Richard J Cohn Journal: Cancers (Basel) Date: 2021-05-18 Impact factor: 6.639